summary
Introduced
02/22/2016
02/22/2016
In Committee
02/22/2016
02/22/2016
Crossed Over
Passed
Dead
01/03/2017
01/03/2017
Introduced Session
114th Congress
Bill Summary
Heroin and Prescription Drug Abuse Prevention and Reduction Act This bill amends the Controlled Substances Act to revise requirements for and limitations on practitioners who dispense narcotic drugs for maintenance or detoxification treatment. The Department of Health and Human Services (HHS) must establish grant programs to: (1) encourage prescribing and purchase of opioid overdose reversal drugs (e.g., naloxone), and (2) develop prescribing guidelines for such drugs. (Opioids are drugs with effects similar to opium, such as heroin or certain pain medications.) The Centers for Disease Control and Prevention must provide support to improve drug overdose surveillance and reporting capabilities. HHS may support syringe exchange programs. The Substance Abuse and Mental Health Services Administration must provide support to reduce drug overdose deaths. This bill amends the Public Health Service Act to extend residential treatment programs for pregnant and postpartum women. HHS must: (1) carry out a pilot program to support services for pregnant and postpartum women with a substance use disorder; (2) award grants to expand treatment activities in areas with a high rate of, or a rapid increase in, the use of opioids; (3) support increasing the capacity of substance use disorder services for adolescents; and (4) develop, expand, and enhance substance use recovery support services. This bill amends the Employee Retirement Income Security Act of 1974 (ERISA) and Internal Revenue Code to direct HHS and the Departments of Labor and the Treasury to require disclosures, issue guidance, conduct audits, and publish information regarding the requirement for group health plans and health insurance coverage to have parity between mental health and substance use disorder benefits and medical and surgical benefits. HHS must establish a consumer parity portal website. HHS must establish a loan repayment program for substance use disorder health professionals.
AI Summary
This bill, the Heroin and Prescription Drug Abuse Prevention and Reduction Act, aims to address the opioid crisis by enhancing prevention, treatment, and recovery services. Key provisions include requiring practitioners who dispense narcotic drugs for maintenance or detoxification treatment to undergo specific training, establishing grant programs to encourage the prescribing and purchase of opioid overdose reversal drugs like naloxone and to develop guidelines for their use, and improving drug overdose surveillance and reporting capabilities. The bill also supports syringe exchange programs, extends residential treatment programs for pregnant and postpartum women, and aims to increase access to substance use disorder services for adolescents and strengthen recovery support services. Furthermore, it mandates increased transparency and enforcement regarding mental health and substance use disorder benefits in group health plans and health insurance coverage, ensuring they are treated comparably to medical and surgical benefits, and establishes a loan repayment program for professionals in the substance use disorder field.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 02/22/2016)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...